Zoledronic acid for the treatment of bone Metastases in patients with breast cancer and other solid tumors

被引：37
|
作者：
Lacerna, L [1 ]
Hohneker, J [1 ]
机构：
[1] Novartis Pharmaceut, Med Affairs, E Hanover, NJ 07936 USA
来源：
SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 05期
关键词：
D O I：
10.1053/j.seminoncol.2003.08.017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：150 / 160
页数：11
相关论文
共 50 条
  • [1] Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors
    Rosen, LS
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (06) : 28 - 32
  • [2] Proven efficacy of zoledronic acid in the treatment of bone metastases in patients with breast cancer and other malignancies
    Cameron, D
    [J]. BREAST, 2003, 12 : S22 - S29
  • [3] Zoledronic acid for the prevention of bone metastases in patients with breast cancer
    Coleman, R.
    Gralow, J.
    Bell, R.
    Lipton, A.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 74 - 75
  • [4] Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial - The zoledronic acid lung cancer and other solid tumors study group
    Rosen, LS
    Gordon, D
    Tchekmedyian, S
    Yanagihara, R
    Hirsh, V
    Krzakowski, M
    Pawlicki, M
    de Souza, P
    Zheng, M
    Urbanowitz, G
    Reitsma, D
    Seaman, JJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3150 - 3157
  • [5] Breast cancer bone metastases: denosumab or zoledronic acid?
    Gabri van der Pluijm
    [J]. Nature Reviews Endocrinology, 2011, 7 : 134 - 135
  • [6] Long-term safety of zoledronic acid for the treatment of patients with breast cancer and bone metastases
    Lipton, A.
    Dewar, R.
    Conte, R.
    Zheng, M.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 142 - 142
  • [7] CANCER Breast cancer bone metastases: denosumab or zoledronic acid?
    van der Pluijm, Gabri
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (03) : 134 - 135
  • [8] Zoledronic acid has broad long-term efficacy in reducing skeletal complications in patients with bone metastases from breast cancer, prostate cancer, and other solid tumors
    Coleman, R
    Rosen, L
    Gleason, DM
    Zheng, M
    [J]. BONE, 2004, 34 : S84 - S85
  • [9] Recommendations for zoledronic acid treatment of patients with bone metastases
    Berenson, JR
    [J]. ONCOLOGIST, 2005, 10 (01): : 52 - 62
  • [10] Zoledronic acid quarterly versus monthly conventional schedule in patients with solid tumors with bone metastases
    Liutti, V. T.
    Piovesana, M. M.
    Kiara, M. S.
    Lucas, G. V.
    Buiar, A. C. K.
    Kasai, C. C. D. S.
    Carvalheira, J. B. C.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1077 - S1077
12345